Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris – A randomized phase II study

Background: An aerosol foam formulation of fixed combination calcipotriene 0.005% (as hydrate; Cal) plus betamethasone dipropionate 0.064% (BD) was developed to improve psoriasis treatment. Objectives: To compare the efficacy and safety of Cal/BD aerosol foam with Cal/BD ointment after 4 weeks. Meth...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Dermatolog Treat
Autors principals: Koo, John, Tyring, Stephen, Werschler, William P., Bruce, Suzanne, Olesen, Martin, Villumsen, John, Bagel, Jerry
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Psoriasis & Phototherapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4772687/
https://ncbi.nlm.nih.gov/pubmed/26444907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/09546634.2015.1083935
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars